| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Krystal Biotech Inc (NASDAQ: KRYS)
KRYS Technical Analysis
5
| As on 9th Jun 2023 KRYS STOCK Price closed @ 128.92 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 67.11 & Strong Buy for SHORT-TERM with Stoploss of 62.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KRYSSTOCK Price
| Open | 127.72 | Change | Price | % |
| High | 129.74 | 1 Day | 0.92 | 0.72 |
| Low | 127.00 | 1 Week | 11.07 | 9.39 |
| Close | 128.92 | 1 Month | 45.05 | 53.71 |
| Volume | 274205 | 1 Year | 57.46 | 80.41 |
| 52 Week High 127.37 | 52 Week Low 48.93 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KRYS Daily Charts |
KRYS Intraday Charts |
Whats New @ Bazaartrend |
KRYS Free Analysis |
|
|
KRYS Important Levels Intraday
| RESISTANCE | 134.20 |
| RESISTANCE | 132.51 |
| RESISTANCE | 131.46 |
| RESISTANCE | 130.41 |
| SUPPORT | 127.43 |
| SUPPORT | 126.38 |
| SUPPORT | 125.33 |
| SUPPORT | 123.64 |
KRYS Forecast May 2024
| 4th UP Forecast | 166.38 |
| 3rd UP Forecast | 154.37 |
| 2nd UP Forecast | 146.94 |
| 1st UP Forecast | 139.51 |
| 1st DOWN Forecast | 118.33 |
| 2nd DOWN Forecast | 110.9 |
| 3rd DOWN Forecast | 103.47 |
| 4th DOWN Forecast | 91.46 |
KRYS Weekly Forecast
| 4th UP Forecast | 140.31 |
| 3rd UP Forecast | 136.66 |
| 2nd UP Forecast | 134.40 |
| 1st UP Forecast | 132.14 |
| 1st DOWN Forecast | 125.70 |
| 2nd DOWN Forecast | 123.44 |
| 3rd DOWN Forecast | 121.18 |
| 4th DOWN Forecast | 117.53 |
KRYS Forecast2024
| 4th UP Forecast | 287.07 |
| 3rd UP Forecast | 236.35 |
| 2nd UP Forecast | 205 |
| 1st UP Forecast | 173.65 |
| 1st DOWN Forecast | 84.19 |
| 2nd DOWN Forecast | 52.84 |
| 3rd DOWN Forecast | 21.49 |
| 4th DOWN Forecast | -29.23 |
Krystal Biotech Inc ( NASDAQ USA Symbol : KRYS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KRYS Business Profile
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and acne scars; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx for other rare lung disease. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania. Address: 2100 Wharton Street, Pittsburgh, PA, United States, 15203
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service